Cilta-Cel Leads to 100% MRD-Negativity Rate in High-Risk Smoldering Multiple Myeloma
Cilta-cel without induction therapy in high-risk smoldering myeloma marked the first study of CAR T-cell therapy in a precursor cancer setting.
Related Articles
Prior CAR T-Cell Therapy Exposure May Impact Odronextamab Benefit in DLBCL
Developing odronextamab combinations following CAR T-cell therapy failure may help elicit responses in patients with diffuse large B-cell lymphoma.
Neoadjuvant Chemoimmunotherapy for NSCLC
This meta-analysis investigates the association of neoadjuvant chemoimmunotherapy with patient benefits vs neoadjuvant chemotherapy in patients with non–small cell lung cancer (NSCLC).
Mirtazapine as Appetite Stimulant in Patients With NSCLC and Anorexia
This randomized clinical trial assesses the effect of mirtazapine on appetite and energy consumption in patients with advanced non–small cell lung cancer (NSCLC).
OCE Conversations on Cancer – Cervical Cancer Treatment Innovation: A Collaborative Discussion
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE
Key PointsZanubrutinib sustained PFS benefit over ibrutinib; sensitivity analyses suggest this was driven by both antileukemic effect and tolerability.Zanu
A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease – The Cancer Letter
City of Hope has received a $150 million gift from entrepreneurs and philanthropists A. Emmet Stephenson Jr. and his daughter Tessa Stephenson Brand to create…
With Fred Hutch from the very start
David and Deborah Lycette are proud of their connection to Fred Hutch’s history, but today they are more interested in its future. Learn more about…
2024 Most Read Articles | Blood Advances | American Society of Hematology
2024 Most Read Articles | Blood Advances | American Society of Hematology Top Ten Most Read Articles in 2024 Blood Advances is pleased to announce…
Registration
Register for the AACR Annual Meeting 2025, taking place April 25-30 in Chicago, Illinois.
